# Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

> **NCT00003031** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 212 (estimated)

## Conditions studied

- Infection
- Pulmonary Complications

## Interventions

- **DRUG:** amphotericin B deoxycholate
- **DRUG:** voriconazole

## Key facts

- **NCT ID:** NCT00003031
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-06
- **Primary completion:** 2000-10
- **Final completion:** —
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2012-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003031, "Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00003031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*